Evonik and Stanford will begin a three-year research collaboration to develop a polymer-based drug delivery system for mRNA therapeutics. German contract development manufacturing organization (CDMO) Evonik will license and commercialize Stanford University’s polymer-based drug delivery system, which enables broader use of messenger RNA (mRNA). The CDMO work will take place at Evonik’s facilities in Vancouver, Canada and Birmingham, USA. “The platform is called CART (Charge Altering Releasable Transporters),†vice president of R&D, Innovation for Evonik Stefan Randl told BioProcess Insider.…
Tuesday, June 22, 2021 Daily Archives
Novartis and Allergopharma sites get EU OK to make Pfizer COVID vaccine
The European Medicines Agency (EMA) has approved sites in Switzerland and Germany for the fill and finish of Pfizer/BioNTech’s COVID-19 vaccine Comirnaty. At the beginning of the year, Pfizer entered into a deal with fellow Big Pharma firm Novartis for the supply of its COVID-19 vaccine Comirnaty, codeveloped with German firm BioNTech. Novartis is providing aseptic manufacturing services from its Stein, Switzerland, facility under a contract manufacturing agreement that sees the company take bulk mRNA active ingredient from BioNTech and…